Monsanto Megan M, White Kevin S, Kim Taeyong, Wang Bingyan J, Fisher Kristina, Ilves Kelli, Khalafalla Farid G, Casillas Alexandria, Broughton Kathleen, Mohsin Sadia, Dembitsky Walter P, Sussman Mark A
From the San Diego Heart Research Institute, San Diego State University, CA (M.M.M., K.S.W., T.K., B.J.W., K.F., K.I., F.G.K., A.C., K.B., S.M., M.A.S.); and Sharp Memorial Hospital, San Diego, CA (W.P.D.).
Circ Res. 2017 Jul 7;121(2):113-124. doi: 10.1161/CIRCRESAHA.116.310494. Epub 2017 Apr 26.
The relative actions and synergism between distinct myocardial-derived stem cell populations remain obscure. Ongoing debates on optimal cell population(s) for treatment of heart failure prompted implementation of a protocol for isolation of multiple stem cell populations from a single myocardial tissue sample to develop new insights for achieving myocardial regeneration.
Establish a robust cardiac stem cell isolation and culture protocol to consistently generate 3 distinct stem cell populations from a single human heart biopsy.
Isolation of 3 endogenous cardiac stem cell populations was performed from human heart samples routinely discarded during implantation of a left ventricular assist device. Tissue explants were mechanically minced into 1 mm pieces to minimize time exposure to collagenase digestion and preserve cell viability. Centrifugation removes large cardiomyocytes and tissue debris producing a single cell suspension that is sorted using magnetic-activated cell sorting technology. Initial sorting is based on tyrosine-protein kinase Kit (c-Kit) expression that enriches for 2 c-Kit cell populations yielding a mixture of cardiac progenitor cells and endothelial progenitor cells. Flowthrough c-Kit mesenchymal stem cells are positively selected by surface expression of markers CD90 and CD105. After 1 week of culture, the c-Kit population is further enriched by selection for a CD133 endothelial progenitor cell population. Persistence of respective cell surface markers in vitro is confirmed both by flow cytometry and immunocytochemistry.
Three distinct cardiac cell populations with individualized phenotypic properties consistent with cardiac progenitor cells, endothelial progenitor cells, and mesenchymal stem cells can be successfully concurrently isolated and expanded from a single tissue sample derived from human heart failure patients.
不同心肌来源干细胞群体之间的相对作用及协同作用仍不清楚。关于治疗心力衰竭的最佳细胞群体的持续争论促使实施一项方案,从单个心肌组织样本中分离多个干细胞群体,以获得实现心肌再生的新见解。
建立一种可靠的心脏干细胞分离和培养方案,以便从单个人类心脏活检样本中持续产生3种不同的干细胞群体。
从左心室辅助装置植入过程中常规丢弃的人类心脏样本中分离出3种内源性心脏干细胞群体。将组织外植体机械切碎成1毫米的小块,以尽量减少胶原酶消化的时间暴露并保持细胞活力。离心去除大的心肌细胞和组织碎片,产生单细胞悬液,使用磁激活细胞分选技术进行分选。初始分选基于酪氨酸蛋白激酶Kit(c-Kit)表达,富集2种c-Kit细胞群体,产生心脏祖细胞和内皮祖细胞的混合物。通过c-Kit间充质干细胞的标志物CD90和CD105的表面表达进行阳性选择。培养1周后,通过选择CD133内皮祖细胞群体进一步富集c-Kit群体。通过流式细胞术和免疫细胞化学证实了体外各自细胞表面标志物的持续性。
可以成功地从源自人类心力衰竭患者的单个组织样本中同时分离并扩增出三种具有与心脏祖细胞、内皮祖细胞和间充质干细胞一致的个性化表型特性的不同心脏细胞群体。